Acutaas ChemicalsNSE:ACUTAAS +0.96%69 EBITDA Margin % is 39.51% as of Dec. 2025, which is 91% above its 10-year median of 20.70. GuruFocus rates NSE:ACUTAAS with a GF Score™ of 69/100 and a GF Value™ of ₹1,303.70 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,585 Chemicals companies, Acutaas Chemicals ranks better than 95.71% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Acutaas Chemicals's EBITDA for the
three
months ended in Dec. 2025 was ₹1,554 Mil. Acutaas Chemicals's Revenue for the
three
months ended in Dec. 2025 was ₹3,932 Mil. Therefore, Acutaas Chemicals's EBITDA margin for the quarter that ended in Dec. 2025 was 39.51%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Acutaas Chemicals EBITDA Margin % Related Terms
Acutaas Chemicals EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Acutaas Chemicals's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ACUTAAS vs LIN, SHW, ECL: EBITDA Margin % Comparison
For the Specialty Chemicals subindustry, Acutaas Chemicals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Acutaas Chemicals EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Acutaas Chemicals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Acutaas Chemicals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Acutaas Chemicals (NSE:ACUTAAS) has a EBITDA Margin % of 39.51% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Acutaas Chemicals and its competitors. This is 91% above median its historical median of 20.70. Over the past decade, Acutaas Chemicals' EBITDA Margin % has ranged from 14.57 to 34.61. According to the industry distribution chart, Acutaas Chemicals ranks #68 out of 1585 companies in the Chemicals industry, placing it in the top 4.3%.
Is Acutaas Chemicals' EBITDA Margin % too high?
Acutaas Chemicals' current EBITDA Margin % of 39.51% is 91% above median its 10-year median of 20.70. Over the past 10 years, this metric has ranged from a low of 14.57 to a high of 34.61. The Chemicals industry median EBITDA Margin % is 9.63. Acutaas Chemicals' value of 39.51% is 310.3% above this industry median. Based on the distribution chart, Acutaas Chemicals ranks #68 out of 1585 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Acutaas Chemicals has a GF Score™ of 69/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Acutaas Chemicals' EBITDA Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, Acutaas Chemicals ranks #68 out of 1585 companies for EBITDA Margin %. This places Acutaas Chemicals in the top 4% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.63. Acutaas Chemicals' value of 39.51% is 310.3% above this benchmark. Historically, Acutaas Chemicals' own EBITDA Margin % has ranged from 14.57 to 34.61 over the past decade. While the company's 10-year median is 20.70 vs. the industry median of 9.63, Acutaas Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.63, based on 1,585 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Acutaas Chemicals's current EBITDA Margin % of 39.51% is 310.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Acutaas Chemicals and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Acutaas Chemicals's current EBITDA Margin % is 39.51%, which is 91% above median its own 10-year median of 20.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acutaas Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Acutaas Chemicals (NSE:ACUTAAS) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹1,303.70, compared to a current price of ₹3,300.00 — trading 153.1% above its estimated fair value. The current EBITDA Margin % is 39.51%, which is 91% above median its 10-year median of 20.70 and 310.3% above the Chemicals industry median of 9.63. Acutaas Chemicals' overall GF Score™ is 69/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Acutaas Chemicals (NSE:ACUTAAS), the current EBITDA Margin % is 39.51% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Acutaas Chemicals (NSE:ACUTAAS) Overvalued in 2026?
Based on GuruFocus' analysis, Acutaas Chemicals stock appears to be overvalued.
The current stock price of ₹3,300.00 is trading 153.1% above its estimated GF Value™ of ₹1,303.70.
GuruFocus considers Acutaas Chemicals to be Significantly Overvalued.
Key valuation signals for NSE:ACUTAAS:
EBITDA Margin %: 39.51% (91% above median its 10-year median of 20.70)
GF Value™: ₹1,303.70 vs. price of ₹3,300.00 (153.1% above fair value)
Industry Position: 310.3% above the Chemicals median (#68 of 1585)
No single metric tells the full story. See the NSE:ACUTAAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Acutaas Chemicals Ltd is principally engaged in the business of drugs intermediate chemicals and related activities. It manufactures different types of pharmaceutical intermediates and active pharmaceutical ingredients, specialty chemicals, and formulations. Its products are used in various industrial sectors, including Pharmaceutical, Personal Care, Cosmetics, Dyes, Polymers, Agro Chemicals, and Animal Foods industries. The company caters to both domestic and international markets and generates the majority of its revenue from outside India.
69GF Score
Get the complete analysis for NSE:ACUTAAS
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACUTAAS has been successfully added to your 
